Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

PIGUET

Showing results (1221-1230 of 1,271) with videos related to

Pageof 128
Sort By:
Human Molecular Genetics|May 21, 2026
Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron diseaseHiu Chuen Lok, Carol Dobson-Stone, Marianne Hallupp, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
British Journal of Haematology|August 2, 2021
Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia: a French Severe Chronic Neutropenia Registry studyGioacchino A Rotulo, Geneviève Plat, Blandine Beaupain, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancerMathilde Delebarre, Fanny Gonzales, Hélène Behal, et al.
The Lancet Regional Health. Western Pacific|October 14, 2024
Regional health priorities for dementia: a roadmap for the Western PacificHannah C Timmins, Vincent C T Mok, Seung Hyun Kim, et al.
Scientific Reports|January 24, 2025
Development of a checklist for cognitive assessment requirements (CARE) based on a Delphi consensus studyVahid Nejati, Reza Estaji, Vicent Balanzá-Martínez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trialB Audinot, D Drubay, N Gaspar, et al.
Haematologica|January 14, 2021
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burdenThomas Pincez, Helder Fernandes, Thierry Leblanc, et al.
Frontiers in Pediatrics|October 21, 2015
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational CohortNathalie Aladjidi, Helder Fernandes, Thierry Leblanc, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
Pageof 128

Showing results (1221-1230 of 1,271) with videos related to

Sort By:
Pageof 128
Human Molecular Genetics|May 21, 2026
Ultra-rare variants in LAMA2 are risk factors for frontotemporal dementia and motor neuron diseaseHiu Chuen Lok, Carol Dobson-Stone, Marianne Hallupp, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
British Journal of Haematology|August 2, 2021
Recurrent bacterial infections, but not fungal infections, characterise patients with ELANE-related neutropenia: a French Severe Chronic Neutropenia Registry studyGioacchino A Rotulo, Geneviève Plat, Blandine Beaupain, et al.
The Lancet. Child & Adolescent Health|December 6, 2021
Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancerMathilde Delebarre, Fanny Gonzales, Hélène Behal, et al.
The Lancet Regional Health. Western Pacific|October 14, 2024
Regional health priorities for dementia: a roadmap for the Western PacificHannah C Timmins, Vincent C T Mok, Seung Hyun Kim, et al.
Scientific Reports|January 24, 2025
Development of a checklist for cognitive assessment requirements (CARE) based on a Delphi consensus studyVahid Nejati, Reza Estaji, Vicent Balanzá-Martínez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2023
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trialB Audinot, D Drubay, N Gaspar, et al.
Haematologica|January 14, 2021
Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burdenThomas Pincez, Helder Fernandes, Thierry Leblanc, et al.
Frontiers in Pediatrics|October 21, 2015
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational CohortNathalie Aladjidi, Helder Fernandes, Thierry Leblanc, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
Pageof 128